Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04594798
Title A Study of Polatuzumab Vedotin, Rituximab and Dose Attenuated CHP in Older Patients With DLBCL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Rochester
Age Groups: senior
Covered Countries USA

No variant requirements are available.